Research Centre, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Canadian National Transplant Research Program, Edmonton, Alberta, Canada.
J Am Soc Nephrol. 2018 Jul;29(7):1900-1916. doi: 10.1681/ASN.2017050581. Epub 2018 Jun 20.
Ischemia-reperfusion injury (IRI) is a major risk factor for chronic renal failure. Here, we characterize the different modes of programmed cell death in the tubular and microvascular compartments during the various stages of IRI-induced AKI, and their relative importance to renal fibrogenesis. We performed unilateral renal artery clamping for 30 minutes and contralateral nephrectomy in wild-type mice (C57BL/6) or caspase-3 mice. Compared with their wild-type counterparts, caspase-3 mice in the early stage of AKI had high urine cystatin C levels, tubular injury scores, and serum creatinine levels. Electron microscopy revealed evidence of tubular epithelial cell necrosis in caspase-3 mice, and immunohistochemistry showed upregulation of the necroptosis marker receptor-interacting serine/threonine-protein kinase 3 (RIPK3) in renal cortical sections. Western blot analysis further demonstrated enhanced levels of phosphorylated RIPK3 in the kidneys of caspase-3 mice. In contrast, caspase-3 mice had less microvascular congestion and activation in the early and extension phases of AKI. In the long term (3 weeks after IRI), caspase-3 mice had reduced microvascular rarefaction and renal fibrosis, as well as decreased expression of -smooth muscle actin and reduced collagen deposition within peritubular capillaries. Moreover, caspase-3 mice exhibited signs of reduced tubular ischemia, including lower tubular expression of hypoxia-inducible factor-1 and improved tubular injury scores. These results establish the pivotal importance of caspase-3 in regulating microvascular endothelial cell apoptosis and renal fibrosis after IRI. These findings also demonstrate the predominant role of microvascular over tubular injury as a driver of progressive renal damage and fibrosis after IRI.
缺血再灌注损伤 (IRI) 是慢性肾衰竭的一个主要危险因素。在这里,我们描述了在 IRI 诱导的 AKI 的各个阶段,肾小管和微血管隔室中程序性细胞死亡的不同模式及其对肾纤维化的相对重要性。我们在野生型 (C57BL/6) 或半胱天冬酶-3 小鼠中进行了单侧肾动脉夹闭 30 分钟和对侧肾切除术。与野生型相比,AKI 早期的半胱天冬酶-3 小鼠尿液胱抑素 C 水平、肾小管损伤评分和血清肌酐水平较高。电子显微镜显示半胱天冬酶-3 小鼠的肾小管上皮细胞坏死证据,免疫组织化学显示肾皮质切片中坏死受体相互作用丝氨酸/苏氨酸蛋白激酶 3 (RIPK3) 的上调。Western blot 分析进一步证明了半胱天冬酶-3 小鼠肾脏中磷酸化 RIPK3 的水平增强。相比之下,半胱天冬酶-3 小鼠在 AKI 的早期和扩展阶段的微血管充血和激活较少。在长期 (IRI 后 3 周),半胱天冬酶-3 小鼠的微血管稀疏和肾纤维化减少,-平滑肌肌动蛋白表达降低,肾小管周围毛细血管内胶原沉积减少。此外,半胱天冬酶-3 小鼠表现出肾小管缺血减少的迹象,包括低管状缺氧诱导因子-1 表达和改善的管状损伤评分。这些结果确立了半胱天冬酶-3 在调节 IRI 后微血管内皮细胞凋亡和肾纤维化中的关键作用。这些发现还表明,微血管损伤而非肾小管损伤作为 IRI 后进行性肾损伤和纤维化的驱动因素具有主导作用。